Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After Stroke

NCT01336153 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Stroke

Interventions

DRUG: MLC601
DRUG: Placebo

Sponsor

Shahid Beheshti University

Collaborators

[object Object]